Skip to main content

MINI REVIEW article

Front. Neurol.
Sec. Dementia and Neurodegenerative Diseases
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1439125

The Role of Inflammation in Neurological Diseases: Multiple Sclerosis, Alzheimer's, and Parkinson's disease: Short review of the literature

Provisionally accepted
Yahveth Cantero-Fortiz Yahveth Cantero-Fortiz 1,2*Merce Boada Merce Boada 1,2
  • 1 Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Madrid, Spain
  • 2 Fundació ACE, Barcelona, Spain

The final, formatted version of the article will be published soon.

    Neuroinflammation is a central feature in the pathophysiology of several neurodegenerative diseases, including MS, AD, and PD. This review aims to synthesize current research on the role of inflammation in these conditions, emphasizing the potential of inflammatory biomarkers for diagnosis and treatment. We highlight recent findings on the mechanisms of neuroinflammation, the utility of biomarkers in disease differentiation, and the implications for therapeutic strategies. Advances in understanding inflammatory pathways offer promising avenues for developing targeted interventions to improve patient outcomes. Future research should focus on validating these biomarkers in larger cohorts and integrating them into clinical practice to enhance diagnostic accuracy and therapeutic efficacy.

    Keywords: CNS, Alzheimer's disease, Multiple Sclerosis, Parkinson's disease, Neuroinflammation, biomarkers

    Received: 27 May 2024; Accepted: 07 Oct 2024.

    Copyright: © 2024 Cantero-Fortiz and Boada. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yahveth Cantero-Fortiz, Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, 28031, Madrid, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.